Nasdaq Nordic: Nasdaq Stockholm Welcomes Calliditas Therapeutics to the Main Market

Stockholm, June 29, 2018 - Nasdaq (Nasdaq: NDAQ) announces that Calliditas
Therapeutics AB (short name: CALTX), a mid cap company within the health care
sector, today will start trading of its shares on the main market of Nasdaq
Stockholm. Calliditas Therapeutics is the 50th company to list on Nasdaq's
Nordic markets* in 2018. 

Calliditas Therapeutics is a specialty pharmaceutical company focused on
developing high value medical products for patients with significant unmet
medical needs in niche indications, where the company can partially or
completely participate in the commercialization. Calliditas is focused on the
development and commercialization of its lead product candidate Nefecon, which
has successfully completed a Phase 2b clinical trial, as a potential new
treatment for patients with inflammatory kidney disease who are at risk of
progressing to renal failure. Calliditas Therapeutics was founded in 2004 and
is headquartered in Stockholm. For more information, please visit
www.calliditas.com. 

"The listing on Nasdaq Stockholm and the capital raise are important landmarks
for Calliditas which enable us to accelerate the development of our lead
product Nefecon through Phase 3 clinical studies and subsequently
commercialization," said Renée Aguiar-Lucander, CEO of Calliditas. "We would
like to thank our existing investors for their continued support and welcome
all new shareholders to Calliditas." 

"We are excited to welcome Calliditas Therapeutics to the Nasdaq Stockholm main
market," said Adam Kostyál, SVP and Head of European listings at Nasdaq.
"Calliditas Therapeutics joins our vibrant health care sector, and we look
forward to supporting the company for many years to come." 

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki,
Nasdaq Iceland and Nasdaq Stockholm. 


About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing,
exchange technology, listing, information and public company services. Through
its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock market, its
technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the
world's securities transactions. Nasdaq is home to 3,900 total listings with a
market value of $13 trillion. To learn more, visit: http://business.nasdaq.com 

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq
Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker
Services are respectively brand names for the regulated markets of Nasdaq
Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS,
Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB
and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq
Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq
Vilnius. 

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements include, but are not limited to, statements about
Nasdaq and its products and offerings. We caution that these statements are not
guarantees of future performance. Actual results may differ materially from
those expressed or implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond
Nasdaq's control. These factors include, but are not limited to factors
detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed
with the U.S. Securities and Exchange Commission. We undertake no obligation to
release any revisions to any forward-looking statements. 

Media Relations Contact: 
Erik Granström           
[phone]         
[e-mail]
-------------------------